2020
DOI: 10.1016/j.semcancer.2019.05.009
|View full text |Cite
|
Sign up to set email alerts
|

Exploring MYC relevance to cancer biology from the perspective of cell competition

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
15
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(16 citation statements)
references
References 198 publications
1
15
0
Order By: Relevance
“…So far, the molecular nature of cell competition has been discussed extensively in Drosophila [21][22][23][24][25], and several driving factors have been identified including c-myc and p53 [26][27][28][29]. In fact, we confirmed augmented expression of c-myc in ACT1 cells (S13 Fig), however, it did not seem to make ACTs cells supercompetitor, since the growth of ACT1 is much slower than NTECs (S2 Fig) . Also, differential expression of Scrib does not appear to be involved as there was no difference between NTECs and ACT1 (S13 Fig) . The p53 gene is mutated in ACT1 cells, so that the p53 protein level is significantly stabilized (S13 Fig) . Together with the mutation in the N-ras gene p53 deregulation could confer the 'winner' phenotype [43], but ACT1 growth was indeed suppressed by the cell competition with NTECs, suggesting that driver mutations may play a different role in different cell context.…”
Section: Plos Onesupporting
confidence: 53%
See 1 more Smart Citation
“…So far, the molecular nature of cell competition has been discussed extensively in Drosophila [21][22][23][24][25], and several driving factors have been identified including c-myc and p53 [26][27][28][29]. In fact, we confirmed augmented expression of c-myc in ACT1 cells (S13 Fig), however, it did not seem to make ACTs cells supercompetitor, since the growth of ACT1 is much slower than NTECs (S2 Fig) . Also, differential expression of Scrib does not appear to be involved as there was no difference between NTECs and ACT1 (S13 Fig) . The p53 gene is mutated in ACT1 cells, so that the p53 protein level is significantly stabilized (S13 Fig) . Together with the mutation in the N-ras gene p53 deregulation could confer the 'winner' phenotype [43], but ACT1 growth was indeed suppressed by the cell competition with NTECs, suggesting that driver mutations may play a different role in different cell context.…”
Section: Plos Onesupporting
confidence: 53%
“…Thus, cell competition is now recognized as a critical player in the development of diseases, such as cancer [8,[20][21][22][23][24][25]. In carcinogenesis, Myc-mediated cell competition is the most wellstudied example [26][27][28][29][30]. Since cells showing higher expression of Myc were demonstrated to cause competitive cell elimination in Drosophila [27,28], many types of cancer cells, which overexpress c-Myc protein [31][32][33][34][35], have been though to enable their expansion in tissues with the aid of c-Myc-mediated super-competition [36,37].…”
Section: Introductionmentioning
confidence: 99%
“…One of the most studied regulators of competition is MYC, a family of proteins that is misregulated and contributes to the development of many cancers. In both flies and humans, overexpression of MYC results in the acquisition of a "superfit" phenotype, enabling these cells to outcompete surrounding normal cells by inducing their elimination (Paglia et al 2020). Subsequent studies showed that loss of the tumor suppressors APC and HIPPO can also induce this "superfit" status (Vermeulen et al 2013;Mamada et al 2015), although these effects may reflect the ability of these alterations to drive the downstream activation of MYC.…”
Section: Cell Competitionmentioning
confidence: 99%
“…It would appear therefore quite reasonable to expect that alterations in these pathways might cause a defective control in the mechanisms of cell competition and, almost inevitably, a parallel increase in the risk of cancer. As an example, the Myc protein is often overexpressed in human cancer[ 43 ] and is also a known driver of cell competition[ 7 ]. Accordingly, cells with up-regulated Myc can express a super-competitor phenotype[ 23 ] and this could contribute, at least theoretically, towards a neoplastic behavior[ 22 ].…”
Section: Cell Competition In the Pathogenesis Of Cancermentioning
confidence: 99%